Weeks 5 through 8: 0.5 mg semaglutide per week
The primary outcome is simple but meaningful: How many heavy drinking days per week they have at the end of the study compared to when they started. Secondary outcomes include changes in WHO risk categories and levels of phosphatidylethanol, a blood biomarker for alcohol use
If you tolerate the new medication well, the dose will be gradually increased until you reach an effective maintenance level
It activates three main receptors: GLP-1, GIP, and glucagon
If somebody comes in with a BMI over 30 and you dont treat it, thats Tuesday. He thinks some of the hesitancy for treating patients with obesity medications comes from the history of dangerous weight loss drugs
About 1 in 8 US adults have used GLP-1s to manage diabetes, treat heart disease, or lose weight